Avalo Therapeutics (AVTX) Q1 2025 Earnings

Mar 20Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-141
-94.06
-47.11
-0.17

Details

Expected EPS
-0.168333
Actual EPS
-2.3
Surprise EPS
-2.13
Surprise Percent
-1,266.34%

Description

⁨Avalo Therapeutics⁩ (⁦AVTX⁩) has reported earnings of ⁦-2.3⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts